ArticleCells2022

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis.

Kentaro Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.